Effect of Unani formulation in Diabetes mellitus
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2021/02/031099
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients of Type-2 Diabetes mellitus taking <=2 Antihyperglycemic drugs.
Gender : Both genders
Fasting blood sugar (FBS) >= 126 mg/dl-<= 250mg/dl
Postprandial blood sugar (PPBS) >=140 mg/dl-<= 350mg/dl
HbA1c >= 6.5% - < 10%
For metabolic control:
BMI 20-35Kg/m2
Waist circumference male>=90 cm, female >=80 cm
Triglycerides <= 499 mg/dl
HDL <40-70 mg/dl
Blood Pressure SBP >= 130 mmHg, or DBP >= 85 mmHg
Fasting blood sugar (FBS) >250mg/dl
Postprandial blood sugar (PPBS) >350mg/dl
HbA1c < 6.5 - > 10%
Triglycerides > 499 mg/dl
HDL >70 mg/dl
Aged <30 â?? >70 years
Known cases of Type-2 Diabetes Mellitus with complications.
Pregnant & lactating Women.
History of any acute diseases or systemic illnesses.
History of any other disorders of metabolism.
Patients who are on medication > 2 antihyperglycemic drugs
changes in the type or dose of antihyperglycemic drugs treatment,
History of smoking, and alcohol abuse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method